The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical evaluation of SIM1803-1A, a small molecule Trk/ROS1 dual inhibitor for wild and mutate NTRK/ROS1 fusion solid malignancies.
 
Jianfei Wang
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
xiaohong yu
Employment - Simcere
Stock and Other Ownership Interests - Simcere
 
Shunwei Zhu
Employment - Simcere
Stock and Other Ownership Interests - Simcere
 
Qingying Chen
Employment - Simcere
Stock and Other Ownership Interests - Simcere
 
Jikui Sun
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
Yuanfeng Xia
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
Yang Zhang
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
Chi-Chung Chan
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
Jian Li
Employment - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec
 
Shuhui Chen
Employment - WuXi AppTec
Leadership - WuXi AppTec
Stock and Other Ownership Interests - WuXi AppTec